Ernexa Therapeutics Inc. (ERNA) earnings
ERNA earnings moved a median of +0.67% by the close. Quarterly and annual ERNA reports and results, each read against the price at its own news timestamp. Back to the ERNA overview →
13 measured ERNA earnings events.
Where these ERNA earnings landedvs 13 measured ERNA earnings reactions
| Middle 50% of ERNA earnings reactions | -3.88% to +1.80% |
|---|---|
| Median reaction (to close) | +0.67% |
| Measured reactions | 13 |
Point-in-time · zero look-ahead
Half of the 13 ERNA earnings events with a measured close landed between -3.88% and +1.80%; 54% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Ernexa Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | — | -3.88% | |
| Form 10-Q Ernexa Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.54% | +60.99% | |
| Form 10-K Ernexa Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.67% | |
| Form 10-Q Ernexa Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.25% | +0.00% | |
| Form 10-Q Ernexa Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | — | +1.25% | |
| Form 10-Q Ernexa Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | -8.05% | -10.32% | |
| Form 10-K Eterna Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | +0.76% | +1.80% | |
| Form 10-Q Eterna Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -20.34% | |
| Form 10-Q Eterna Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | — | -3.06% | |
| Form 10-Q Eterna Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -9.79% | |
| Form 10-K/A Eterna Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | -4.00% | +4.44% | |
| Form 10-K Eterna Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +6.86% | |
| Form 10-Q Eterna Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +1.77% |
Keep exploring
More ERNA: analyst actions → · SEC filings → · ERNA overview →